glp 1 based therapeutics summit Home About GLP-1 Based Therapeutics Summit:

Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Some days you feel nauseous at the sight of food, and on others you forget to eat entirely

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease

Unfortunately, misinformation about these medications has also taken the Internet by storm

Its a functional disorder affecting your stomach nerves and muscles.

Tricare coverage for Ozempic and Wegovy depends on plan type and clinical indication